Drug Profile
Long acting relaxin - Ambrx/Bristol-Myers Squibb
Alternative Names: ARX-720Latest Information Update: 13 Mar 2024
Price :
$50
*
At a glance
- Originator Ambrx
- Developer Ambrx; Bristol-Myers Squibb
- Class Heart failure therapies; Peptide hormones
- Mechanism of Action Relaxin replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Heart failure